A recently published report, sponsored by Novartis, has described the potential benefits of the NHS only paying for drugs that actually work as a new model to address affordability and reduce risks within the health system.
NHS money
The report from the Social Market Foundation (SMF) discusses the challenges faced by the NHS, which encompass not only budget constraints but also growing strain on the system due to an increasing population. Additionally, it notes the effect the reform agenda of personalised outcomes-based care, which is gathering pace, has on the healthcare system.